These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10900980)

  • 21. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
    Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Several possibilities of organizing multimodal treatment of patients with pulmonary tuberculosis].
    Savula MM; Kravchenko NS
    Probl Tuberk; 2001; (8):26-8. PubMed ID: 11767385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tuberculous meningitis developing during course of chemotherapy for tuberculosis including isoniazid--report of two cases.
    Mital VN; Misra M; Gupta OP
    J Assoc Physicians India; 1980 Sep; 28(9):311-3. PubMed ID: 7462137
    [No Abstract]   [Full Text] [Related]  

  • 24. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
    Khudushina TA; Voloshina EP; Adamovich NV; Maslakova MG; Terekhova ND
    Probl Tuberk Bolezn Legk; 2005; (12):37-9. PubMed ID: 16496762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Early results of non-effective chemotherapy with second-line drugs in pulmonary tuberculosis].
    Niemirowska H; Potworowska M
    Gruzlica; 1967 Dec; 35(12):1257-64. PubMed ID: 6079439
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum hexosamine, iron, and total iron-binding capacity during drug treatment of pulmonary tuberculosis.
    Tani P; Kokkola K
    Scand J Respir Dis Suppl; 1972; 80():143-51. PubMed ID: 4510911
    [No Abstract]   [Full Text] [Related]  

  • 27. Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection.
    Yu WC; Lai ST; Chiu MC; Chau TN; Ng TK; Tam CM
    Int J Tuberc Lung Dis; 2006 Jul; 10(7):824-5. PubMed ID: 16850548
    [No Abstract]   [Full Text] [Related]  

  • 28. The treatment of tuberculosis.
    Brewin A
    Ration Drug Ther; 1976 Oct; 10(10):1-5. PubMed ID: 968044
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation of the efficiency of activity of the liposomal form of isoniazid against different types of mycobacteria in vitro].
    Golyshevskaia VI; Selishcheva AA; Martynova LP; Lepekha LN; Kalashnikova TM; Kornilova ZKh; Erokhin VV; Rozenberg OA
    Probl Tuberk Bolezn Legk; 2006; (8):61-4. PubMed ID: 17002062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis.
    Pandey R; Sharma S; Khuller GK
    Int J Antimicrob Agents; 2004 Apr; 23(4):414-5. PubMed ID: 15081096
    [No Abstract]   [Full Text] [Related]  

  • 31. Do we have evidence for policy changes in the treatment of children with latent tuberculosis infection?
    Lobato MN; Jereb JA; Castro KG
    Pediatrics; 2009 Mar; 123(3):902-3. PubMed ID: 19255018
    [No Abstract]   [Full Text] [Related]  

  • 32. Importance of acetylation and oxidation in inactivation of isonicotinic acid hydrazide preparations.
    Smirnov GA
    Fed Proc Transl Suppl; 1966; 25(1):72-6. PubMed ID: 5322111
    [No Abstract]   [Full Text] [Related]  

  • 33. [The new combined antituberculous drug: the original combined antituberculous drug dioxazid].
    Glushkov RG; Sokolova GB; Krylova LIu; Stebaeva LF; Sharova SA
    Probl Tuberk Bolezn Legk; 2007; (3):20-5. PubMed ID: 17500222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures.
    Tam CM; Chan SL; Kam KM; Goodall RL; Mitchison DA
    Int J Tuberc Lung Dis; 2002 Jan; 6(1):3-10. PubMed ID: 11931398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of regional lymphotropic therapy in the treatment of pulmonary tuberculosis in HIV-infected individuals].
    Panteleev AM; Ivanov AK; Vinogradova EN
    Probl Tuberk Bolezn Legk; 2004; (6):26-8. PubMed ID: 15315127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case series: initial outcome of persons with multidrug-resistant tuberculosis after treatment with the WHO standard retreatment regimen in Ho Chi Minh City, Vietnam.
    Lan NTN ; Lademarco MF; Binkin NJ; Tung LB; Quy HT; Cĵ NV
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):575-8. PubMed ID: 11409587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pulmonary tuberculosis in elderly patients].
    Shiraishi Y
    Kyobu Geka; 2005 Jul; 58(8 Suppl):724-8. PubMed ID: 16097626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevention, detection and treatment of pulmonary tuberculosis].
    Press P
    Rev Med Suisse Romande; 1982 Mar; 102(3):249-55. PubMed ID: 7100727
    [No Abstract]   [Full Text] [Related]  

  • 39. [Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents].
    Gubkina MF; Ershova NG
    Probl Tuberk Bolezn Legk; 2009; (1):33-6. PubMed ID: 19256010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Enhancing the effectiveness of chemotherapy for pulmonary tuberculosis by phytotherapy in patients with different genetic markers].
    Tashpulatova FK; Ubaĭdullaev AM
    Probl Tuberk; 2002; (12):46-9. PubMed ID: 12611337
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.